DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

被引：0
|
作者：
Capecchi, M. [1 ]
Corradini, P. [1 ]
Montefusco, V. [1 ]
机构：
[1] Ist Nazl Tumori, Ematol Trapianto Midollo Osseo, Milan, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1983
引用
收藏
页码：795 / 796
页数：2
相关论文
共 50 条
  • [21] Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review
    Al-Ani, Fatimah
    Louzada, Martha L.
    Bastida Bermejo, Jose Maria
    Victoria Mateos, Maria
    BLOOD, 2015, 126 (23)
  • [22] Lenalidomide Related Diarrhea Correlates With Survival In Multiple Myeloma
    Faiman, Beth
    Sidana, Surbhi
    Elson, Paul
    Bruening, Kellie
    Duong, Hien K.
    Dean, Robert M.
    Valent, Jason
    Samaras, Christy
    Hastings, Debbie
    Smith, Mitchell R.
    Reu, Frederic J.
    BLOOD, 2013, 122 (21)
  • [23] MOBILIZATION OF HEMATOPOIETIC PROGENITORS IN PATIENTS WITH MULTIPLE MYELOMA EXPOSED TO LENALIDOMIDE AND POMALIDOMIDE. EXPERIENCE IN A CENTER
    Fernandez, Poveda Elena
    Blanquer, Blanquer Miguel
    Sanchez, Salinas Andres
    Garcia, Hernandez Ana
    Cabanas, Perianes Valentin
    Moya, Arnao Maria
    Martinez, Marin Amelia
    Navarro, Almenzar Begona
    Leal, Rubio Juan Diego
    Sandhez, Villalobos Maria
    Serrano, Jara Claudia
    Moraleda, Jimenez J. M.
    HAEMATOLOGICA, 2020, 105 : 279 - 280
  • [24] Pomalidomide in lenalidomide-refractory multiple myeloma: Far from futile
    Mo, Clifton C.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 483 - 485
  • [25] Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
    Rifkin, Robert M.
    Abonour, Rafat
    Shah, Jatin J.
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James W.
    Lu, Jane Jie
    Kenvin, Laurie
    Srinivasan, Shankar
    Knight, Robert
    Nagarwala, Yasir
    Durie, Brian G. M.
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2228 - 2231
  • [26] Atezolizumab in Combination with Daratumumab with or without Lenalidomide or Pomalidomide: A Phase Ib Study in Patients with Multiple Myeloma
    Cho, Hearn Jay
    Costa, Luciano J.
    Davies, Faith E.
    Neparidze, Natalia
    Vij, Ravi
    Feng, Yuning
    Teterina, Anastasia
    Fritsch, Elisabeth Wassner
    Wenger, Michael
    Kaufman, Jonathan L.
    BLOOD, 2018, 132
  • [27] Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
    Meletios Dimopoulos
    Katja Weisel
    Philippe Moreau
    Larry D. Anderson
    Darrell White
    Jesus San-Miguel
    Pieter Sonneveld
    Monika Engelhardt
    Matthew Jenner
    Alessandro Corso
    Jan Dürig
    Michel Pavic
    Morten Salomo
    Eva Casal
    Shankar Srinivasan
    Xin Yu
    Tuong Vi Nguyen
    Tsvetan Biyukov
    Teresa Peluso
    Paul Richardson
    Leukemia, 2021, 35 : 1722 - 1731
  • [28] Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
    Gooding, Sarah
    Ansari-Pour, Naser
    Towfic, Fadi
    Ortiz Estevez, Maria
    Chamberlain, Philip P.
    Tsai, Kao-Tai
    Flynt, Erin
    Hirst, Marissa
    Rozelle, Dan
    Dhiman, Paula
    Neri, Paola
    Ramasamy, Karthik
    Bahlis, Nizar
    Vyas, Paresh
    Thakurta, Anjan
    BLOOD, 2021, 137 (02) : 232 - 237
  • [29] Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
    Dimopoulos, Meletios
    Weisel, Katja
    Moreau, Philippe
    Anderson, Larry D., Jr.
    White, Darrell
    San-Miguel, Jesus
    Sonneveld, Pieter
    Engelhardt, Monika
    Jenner, Matthew
    Corso, Alessandro
    Duerig, Jan
    Pavic, Michel
    Salomo, Morten
    Casal, Eva
    Srinivasan, Shankar
    Yu, Xin
    Nguyen, Tuong Vi
    Biyukov, Tsvetan
    Peluso, Teresa
    Richardson, Paul
    LEUKEMIA, 2021, 35 (06) : 1722 - 1731
  • [30] Pooled analysis of the reports of pomalidomide after failure of lenalidomide and (or) bortezomib for multiple myeloma
    Sheng, Zhixin
    Liu, Guangyu
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (02) : 102 - 107
12345